Top Markets
Coin of the day
TheraVet S.A. TheraVet S.A.

TheraVet S.A.

ALVET
Rang in aandelen #40004
TheraVet S.A. operates as a veterinary biotechnology firm, delivering... TheraVet S.A. operates as a veterinary biotechnology firm, delivering specialized osteoarticular therapies for animals across Belgium, France, Switzerland, the United Kingdom, and the United States. The company's primary focus is on providing solutions for osteoarthritis, ligament and tendon damage, and bone surgery requirements in felines, canines, and equines. Its product lineup includes BIOCERA-VET, formulated to enhance bone integration and remodeling, and VISCO-VET. The latter is an injectable, hyaluronic acid-based gel that facilitates regeneration, exhibits anti-inflammatory characteristics, boosts the effectiveness of active compounds, and promotes cellular colonization essential for tissue repair. Founded in 2017, TheraVet S.A. has its corporate base situated in Jumet, Belgium.
Aandeelprijs
$0.08585084
Laatst gesynchroniseerd: 2025-02-24
Marktkapitalisatie
$276.78K
Verandering (1 dag)
0.05%
Verandering (1 jaar)
0.00%
Land
BE
Handel TheraVet S.A. (ALVET)

Categorie

Dividendrendementgeschiedenis voor TheraVet S.A. (ALVET)
Het dividendrendement (TTM) van TheraVet S.A. (aandelsymbool: ALVET) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van TheraVet S.A. (ALVET) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten